Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ferrini

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
European Journal of Immunology|March 10, 2001
In vitro stimulation of human tonsillar subepithelial B cells: requirement for interaction with activated T cellsM Dono, S Zupo, R Massara, et al.
Journal of Endocrinological Investigation|July 1, 1979
Study of bioassayable somatomedin on renal artery and veinF Minuto, A Barreca, P Grimaldi, et al.
Gene Therapy|November 14, 1998
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancerM Pizzato, E Franchin, P Calvi, et al.
Scandinavian Journal of Immunology|April 1, 1994
Characterization of a cyclosporin A-sensitive activation pathway in cultured T and natural killer cellsC Cantoni, A Cambiaggi, S Sforzini, et al.
Clinical Immunology and Immunopathology|May 1, 1988
Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroidM Bagnasco, D Venuti, I Prigione, et al.
Scandinavian Journal of Immunology|March 1, 1991
Activated CD3- CD16+ natural killer cells express a subset of the lymphokine genes induced in activated alpha beta + and gamma delta + T cellsR Biassoni, S Ferrini, I Prigione, et al.
International Journal of Cancer|October 15, 1987
Phenotypic and functional analysis of human CD3+ and CD3- clones with "lymphokine-activated killer" (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce interleukin-2M C Mingari, S Ferrini, D Pende, et al.
International Immunology|April 1, 1995
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine productionM C Mingari, C Vitale, A Cambiaggi, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering moleculesS Ferrini, A Cambiaggi, C Cantoni, et al.
Acta Endocrinologica|February 1, 1983
T lymphocyte subpopulations in Graves' disease: relationship with clinical conditionsM Bagnasco, G W Canonica, S Ferrini, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
European Journal of Immunology|March 10, 2001
In vitro stimulation of human tonsillar subepithelial B cells: requirement for interaction with activated T cellsM Dono, S Zupo, R Massara, et al.
Journal of Endocrinological Investigation|July 1, 1979
Study of bioassayable somatomedin on renal artery and veinF Minuto, A Barreca, P Grimaldi, et al.
Gene Therapy|November 14, 1998
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancerM Pizzato, E Franchin, P Calvi, et al.
Scandinavian Journal of Immunology|April 1, 1994
Characterization of a cyclosporin A-sensitive activation pathway in cultured T and natural killer cellsC Cantoni, A Cambiaggi, S Sforzini, et al.
Clinical Immunology and Immunopathology|May 1, 1988
Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroidM Bagnasco, D Venuti, I Prigione, et al.
Scandinavian Journal of Immunology|March 1, 1991
Activated CD3- CD16+ natural killer cells express a subset of the lymphokine genes induced in activated alpha beta + and gamma delta + T cellsR Biassoni, S Ferrini, I Prigione, et al.
International Journal of Cancer|October 15, 1987
Phenotypic and functional analysis of human CD3+ and CD3- clones with "lymphokine-activated killer" (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce interleukin-2M C Mingari, S Ferrini, D Pende, et al.
International Immunology|April 1, 1995
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine productionM C Mingari, C Vitale, A Cambiaggi, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering moleculesS Ferrini, A Cambiaggi, C Cantoni, et al.
Acta Endocrinologica|February 1, 1983
T lymphocyte subpopulations in Graves' disease: relationship with clinical conditionsM Bagnasco, G W Canonica, S Ferrini, et al.
Pageof 15